Posenacaftor structure
|
Common Name | Posenacaftor | ||
---|---|---|---|---|
CAS Number | 2095064-05-2 | Molecular Weight | 445.51 | |
Density | N/A | Boiling Point | N/A | |
Molecular Formula | C27H27NO5 | Melting Point | N/A | |
MSDS | N/A | Flash Point | N/A |
Use of PosenacaftorPosenacaftor (PTI-801) is a cystic fibrosis transmembrane regulator (CFTR) protein modulator that corrects the folding and trafficking of CFTR protein. Posenacaftor is used for the research of cystic fibrosis (CF)[1]. |
Name | Posenacaftor |
---|
Description | Posenacaftor (PTI-801) is a cystic fibrosis transmembrane regulator (CFTR) protein modulator that corrects the folding and trafficking of CFTR protein. Posenacaftor is used for the research of cystic fibrosis (CF)[1]. |
---|---|
Related Catalog | |
In Vitro | Cystic fibrosis (CF) is an autosomal recessive disorder, caused by mutations of the cystic fibrosis transmembrane conductance regulator (CFTR)[1]. CFTR is a cAMP-regulated chloride channel that is primarily located at the apical membrane of epithelial cells. Mutations in the CFTR gene lead to the production of a defective and misfolded CFTR protein, and impairs the flow of ions in and out of cells[1]. Posenacaftor is a CFTR corrector, correctors are designed to fix and restore the function of the defective CFTR protein. The corrected CFTR then moves to the cell surface, where it functions as a chloride channel and helps maintain the right balance of fluid in the airways[2]. |
References |
Molecular Formula | C27H27NO5 |
---|---|
Molecular Weight | 445.51 |